Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
CyanConnode
1H’22 update: strong shipments and cash inflows
20th Oct 2021
Tissue Regenix
Faster-than-anticipated recovery
19th Oct 2021
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
36: Buying Mobeus and the state of the VCT market | Bevan Duncan, Managing Director, Strategic Equity at Gresham House (Baronsmead)
Stay up-to-date with the latest research
Sign up to our newsletter
Highly Commended 'Best Journalist or Advocate' -
EISA Award | The EIS Navigator Podcast
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
CyanConnode
Technology
1H’22 update: strong shipments and cash inflows
By
Milan Radia
20 Oct 2021
Tissue Regenix
Life Sciences
Faster-than-anticipated recovery
By
Dr Martin Hall
19 Oct 2021
Stay up-to-date with the latest research
Sign up to our newsletter
City of London Investment Group
Investment Companies
Good performance offsets weak markets
By
Dr Brian Moretta
18 Oct 2021
WET
Utilities
Monetising its Water R&D
By
Nigel Hawkins
15 Oct 2021
Research reach and investor engagement
By
Keith Hiscock
15 Oct 2021
London Medical Laboratory
Life Sciences
Testing the market…clinically speaking
By
Dr Martin Hall
04 Oct 2021
The Monthly: October 2021
01 Oct 2021
Cizzle Biotechnology/Bould
Life Sciences
Keeping on-track
By
Dr Martin Hall
30 Sep 2021
Filta Group
Consumer
Strong recovery continues
By
Jason Streets
24 Sep 2021
Fidelity European Trust Plc
Financials
FEV: follow the money
By
Mark Thomas
21 Sep 2021
City of London Investment Group
Financials
Results full of cash
By
Dr Brian Moretta
20 Sep 2021
1
2
3
...
54
Next
